1
Return

Efficacy of ambroxol hydrochloride and clenbuterol hydrochloride oral solution, its influencing factors, and its effect on quality of life in child patients with lower respiratory tract infections and symptoms of mucoid sputum

delete2026-04-01
delete0
PRE
AI
H
Hu, Bing
L
Liu, Enmei
J
Jinhai Ma
L
Liu, Changshan
L
Lu, Quan
X
Xiaoyan Dong
H
Huifen Zi
C
Chuangli Hao
R
Rongjun Lin
Z
Zheng, Xiangrong
B
B B Li
F
Fenhua Chen
M
Mei Fang
W
Weimin Tian
Z
Zhiqiang Zhuo
D
Deyu Zhao
Y
Yuejie Zheng
Y
Yong Yin
Q
Q Y Tang
L
Liqun Wu
J
Jinzhun Wu
L
Liyi He
T
Tao Ai
L
Liu, Hanmin
Z
Zhiying Han
Y
Yunbo Mo
Z
Zhiliang Tian
Z
Zhimin Chen *
DOI:10.1016/j.rmed.2026.108758delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Objective Ambroxol hydrochloride and clenbuterol hydrochloride oral solution (AHCHOS) is an agent with mucolytic and bronchodilator functions, but its clinical application in child patients with lower respiratory tract infections (LRTI) and symptoms of mucoid sputum needs more investigation. This study aimed to investigate efficacy of AHCHOS, its influencing factors, and effect on quality of life in these patients. Methods This study enrolled 254 hospitalized child patients with LRTI and symptoms of mucoid sputum receiving AHCHOS. Results Total cough of respiratory symptom (QS) score and QS scores of each subscale (cough, amount of sputum, difficulty in expectoration, and wheeling rale) on the 7th day (D7) were decreased than those at baseline (all P < 0.001). After multivariate logistic regression analysis, non parental guardian status (OR = 25.641, P = 0.020), respiratory rate (OR = 1.075, P = 0.019), and neutrophil percentage (OR = 1.034, P = 0.026) were independently related to higher possibility of absolute value of change of total QS score>5. Quality of life visual analog scale score on D7 was reduced than that at baseline (P < 0.001). Medication compliance was 98.00% on the 4th day, 92.68% on D7, 76.00% on the 14th day, and 75.95% on the 28th day. No adverse event occurred. Conclusion AHCHOS alleviates respiratory symptoms and improves quality of life with good safety in child patients with LRTI and symptoms of mucoid sputum, which is more beneficial for those with elevated respiratory rate, higher neutrophil percentage, and nonparental guardians.
Keywords:
Ambroxol hydrochloride and clenbuterol hydrochloride oral solution
Childhood lower respiratory tract infections
Respiratory symptoms
Quality of life
Medication compliance

Journal

Respiratory Medicine cover
Respiratory Medicine
IF:
3.1
Papers:
7.8K
Citations:
1.4W

Organization

C
Chongqing Medical University
Scholars:
5.9K
Papers: 1.5K
Citations: 2.8W
T
tianjin medical university
Scholars:
3.8K
Papers: 1.0K
Citations: 0
S
shanghai jiao tong university
Scholars:
15.1W
Papers: 11.5W
Citations: 159
F
fudan university
Scholars:
11.3W
Papers: 7.6W
Citations: 121
C
central south university
Scholars:
1.7W
Papers: 5.0K
Citations: 3
S
Sun Yat sen University
Scholars:
5.9K
Papers: 1.6K
Citations: 1.8W
F
fujian medical university
Scholars:
2.7W
Papers: 1.3W
Citations: 13
H
Harbin Medical University
Scholars:
2.9W
Papers: 1.3W
Citations: 1.6W
S
shantou university
Scholars:
2.2K
Papers: 725
Citations: 0
N
ningxia medical university
Scholars:
1.5K
Papers: 437
Citations: 0
S
sichuan university
Scholars:
11.5W
Papers: 7.6W
Citations: 100
X
Xiamen Medical College
Scholars:
1.1K
Papers: 624
Citations: 510
S
soochow university - china
Scholars:
5.1W
Papers: 3.5W
Citations: 82
Q
qingdao university
Scholars:
5.0K
Papers: 1.5K
Citations: 0
B
beijing university of chinese medicine
Scholars:
1.3W
Papers: 5.5K
Citations: 13
N
nanjing medical university
Scholars:
6.9K
Papers: 1.8K
Citations: 2
X
xiamen university
Scholars:
5.7W
Papers: 3.7W
Citations: 67
Z
zhejiang university
Scholars:
17.0W
Papers: 11.9W
Citations: 152
Cited Papers

Cited Papers

Citing Papers

Citing Papers